Cargando…
Opioid antagonism modulates wanting-related frontostriatal connectivity
Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neuro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598157/ https://www.ncbi.nlm.nih.gov/pubmed/34761749 http://dx.doi.org/10.7554/eLife.71077 |
_version_ | 1784600755544522752 |
---|---|
author | Soutschek, Alexander Weber, Susanna C Kahnt, Thorsten Quednow, Boris B Tobler, Philippe N |
author_facet | Soutschek, Alexander Weber, Susanna C Kahnt, Thorsten Quednow, Boris B Tobler, Philippe N |
author_sort | Soutschek, Alexander |
collection | PubMed |
description | Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Reducing opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. In contrast, reducing dopaminergic neurotransmission with amisulpride revealed no robust effects on behavior or neural activity. Our findings thus provide insights into how opioid receptors mediate neural connectivity related to specifically motivational, not hedonic, aspects of rewards. |
format | Online Article Text |
id | pubmed-8598157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-85981572021-11-19 Opioid antagonism modulates wanting-related frontostriatal connectivity Soutschek, Alexander Weber, Susanna C Kahnt, Thorsten Quednow, Boris B Tobler, Philippe N eLife Neuroscience Theoretical accounts distinguish between motivational (‘wanting’) and hedonic (‘liking’) dimensions of rewards. Previous animal and human research linked wanting and liking to anatomically and neurochemically distinct brain mechanisms, but it remains unknown how the different brain regions and neurotransmitter systems interact in processing distinct reward dimensions. Here, we assessed how pharmacological manipulations of opioid and dopamine receptor activation modulate the neural processing of wanting and liking in humans in a randomized, placebo-controlled, double-blind clinical trial. Reducing opioid receptor activation with naltrexone selectively reduced wanting of rewards, which on a neural level was reflected by stronger coupling between dorsolateral prefrontal cortex and the striatum under naltrexone compared with placebo. In contrast, reducing dopaminergic neurotransmission with amisulpride revealed no robust effects on behavior or neural activity. Our findings thus provide insights into how opioid receptors mediate neural connectivity related to specifically motivational, not hedonic, aspects of rewards. eLife Sciences Publications, Ltd 2021-11-11 /pmc/articles/PMC8598157/ /pubmed/34761749 http://dx.doi.org/10.7554/eLife.71077 Text en © 2021, Soutschek et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Neuroscience Soutschek, Alexander Weber, Susanna C Kahnt, Thorsten Quednow, Boris B Tobler, Philippe N Opioid antagonism modulates wanting-related frontostriatal connectivity |
title | Opioid antagonism modulates wanting-related frontostriatal connectivity |
title_full | Opioid antagonism modulates wanting-related frontostriatal connectivity |
title_fullStr | Opioid antagonism modulates wanting-related frontostriatal connectivity |
title_full_unstemmed | Opioid antagonism modulates wanting-related frontostriatal connectivity |
title_short | Opioid antagonism modulates wanting-related frontostriatal connectivity |
title_sort | opioid antagonism modulates wanting-related frontostriatal connectivity |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598157/ https://www.ncbi.nlm.nih.gov/pubmed/34761749 http://dx.doi.org/10.7554/eLife.71077 |
work_keys_str_mv | AT soutschekalexander opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity AT webersusannac opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity AT kahntthorsten opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity AT quednowborisb opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity AT toblerphilippen opioidantagonismmodulateswantingrelatedfrontostriatalconnectivity |